Anne Chevrel and Cécile Durand will represent Mabqi at the Antibody Engineering & Therapeutics Europe congress, taking place from June 10 to 12, 2025, at the Congress Center in Basel, Switzerland.
This leading European event brings together top academic and industry experts to share the latest innovations in antibody discovery, engineering, and therapeutic development. Key topics will include neurodegeneration, metabolism, autoimmune diseases, and more.
Mabqi will also be presenting a scientific poster highlighting recent developments in our antibody research, particularly our innovative conditionally active pH-dependent antibody library and discovery workflow.
This will be a great opportunity to share our progress with the broader scientific community and engage in meaningful discussions with peers and collaborators.
The congress will provide a valuable opportunity for Mabqi to strengthen collaborations and showcase its commitment to advancing therapeutic antibody and protein engineering.
